Westlake Chemical Partners reports Q2 EPS 41c vs. last year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 05 2025
0mins
Should l Buy WLKP?
Q2 Financial Performance: The Partnership reported a Q2 revenue of $297.12M, an increase from $284.17M last year, attributed to higher production and sales at the Petro 1 facility after a turnaround period.
Future Outlook: CEO Jean-Marc Gilson anticipates improvements in distributable cash flow and coverage ratio in the second half of 2025, following the completion of the Petro 1 turnaround.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WLKP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WLKP
About WLKP
Westlake Chemical Partners LP is a limited partnership formed by Westlake Corporation to operate, acquire, and develop ethylene production facilities and other qualified assets. Its business and operations are conducted through OpCo. OpCo's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, as well as an ethylene pipeline, which primarily converts ethane into ethylene and has an aggregate annual capacity of approximately 3.7 billion pounds, and a 200-mile ethylene pipeline. It owns two ethylene production facilities at Westlake's Lake Charles, Louisiana site (Petro 1 and Petro 2, collectively Lake Charles Olefins), with an annual combined capacity of approximately 3.0 billion pounds. The Company owns one ethylene production facility at Westlake's Calvert City, Kentucky site (Calvert City Olefins), with an annual capacity of approximately 730 million pounds.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Westlake Chemical Partners Q1 2026 Earnings Call Insights
- Stable Financial Performance: Westlake Chemical Partners reported a net income of $14 million for Q1 2026, translating to $0.40 per unit, which is $9 million higher than the same period in 2025, primarily driven by increased production and sales volumes, demonstrating the company's resilience amid market volatility.
- Cash Flow and Distribution: The partnership generated $18 million in distributable cash flow for the quarter, or $0.51 per unit, with a trailing 12-month coverage ratio improving from 0.8x to 1x, indicating enhanced cash generation and capital allocation, which boosts investor confidence.
- Management Transition: The company announced that Jon Baksht will join as CFO on June 15, with Steve Bender transitioning to Special Adviser, aiming to optimize financial management and support future strategic growth initiatives.
- Optimistic Market Outlook: The disruption in raw material supply due to the Middle East conflict has led to increased demand and prices for North American ethylene, with management anticipating continued opportunities for third-party sales, although most ethylene sales remain under fixed-margin agreements, ensuring business stability.
See More
Westlake Chemical Partners Reports Strong Q1 Earnings
- Significant Earnings Growth: Westlake Chemical Partners reported a Q1 GAAP EPS of $0.40, indicating a strong performance and enhanced profitability compared to the previous year, which reflects the company's resilience in the market.
- Substantial Revenue Increase: The company achieved revenues of $305.68 million in Q1, marking a 28.6% year-over-year growth, showcasing sustained demand in the chemical sector and further solidifying its market position.
- Executive Appointment: Westlake Chemical Partners appointed Jonathan Baksht as CFO, aiming to strengthen financial management and strategic planning to support the company's long-term growth objectives.
- Attractive Dividend Yield: Amid market volatility, Westlake Chemical Partners ranks among the top ten material stocks with the highest dividend yield, drawing investor interest and potentially enhancing shareholder returns and market appeal.
See More
Westlake Chemical Partners Declares Quarterly Dividend
- Quarterly Dividend Announcement: Westlake Chemical Partners declares a quarterly dividend of $0.4714 per share, consistent with previous distributions, demonstrating the company's ongoing commitment to stable cash flow and shareholder returns.
- Forward Yield: The forward yield of 8.32% positions the company attractively for investors seeking stable income amidst volatile markets, enhancing its appeal in the capital markets.
- Record Date for Shareholders: The dividend will be payable on June 1, with a record date of May 14 and an ex-dividend date also on May 14, providing investors with a clear timeline for their investment decisions.
- Financial Transparency: Westlake Chemical Partners offers a dividend scorecard, yield chart, and dividend growth information, further enhancing transparency and trust among investors regarding the company's financial health.
See More
Westlake Chemical Partners to Announce Q1 Earnings on May 5
- Earnings Announcement Schedule: Westlake Chemical Partners is set to release its Q1 2023 earnings report on May 5 before market open, with a consensus EPS estimate of $0.40, providing crucial insights into the company's recent financial performance for investors.
- Market Expectation Analysis: This earnings release will be a pivotal moment for investors to assess Westlake Chemical Partners' financial health, especially against the backdrop of increasing market volatility, as analyst expectations for profitability will directly impact stock price movements.
- High Dividend Stock Focus: Amid heightened market uncertainty, Westlake Chemical Partners is listed among the top ten material stocks with the highest dividend yield, which may attract income-seeking investors and further enhance its market appeal.
- Management Changes: Westlake Chemical Partners recently appointed Jonathan Baksht as CFO, a move that could bring new financial strategic direction to the company, influencing future financial decisions and investor confidence.
See More
Westlake Chemical Partners Appoints New CFO
- Executive Appointment: Westlake Chemical Partners has appointed Jonathan Baksht as CFO effective June 15, 2026, replacing retiring M. Steven Bender, and Baksht's extensive experience in oil and gas, packaging, and building products is expected to bring new financial strategies to the company.
- Background Overview: Baksht previously served as EVP and CFO at Fortune Brands Innovations and held CFO positions at Pactiv Evergreen and Valaris, and his diverse industry background is anticipated to enhance Westlake's financial management capabilities.
- Board Role: Baksht will also assume the role of director at Westlake Chemical Partners GP LLC on the same date, further strengthening his influence in corporate governance, which is expected to improve the company's financial transparency and strategic decision-making.
- Future Outlook: Westlake Chemical anticipates a recovery in distributable cash flow in 2026, and Baksht's addition may accelerate this process, especially with no planned major turnarounds, thereby boosting market confidence in the company's financial health.
See More
Westlake Chemical Partners Appoints New Executive
- Executive Appointment: Westlake Chemical Partners (WLKP) announced a new executive appointment late Monday, aimed at enhancing the management team's expertise and market competitiveness.
- Strategic Shift: This appointment reflects the company's focus on future growth, which is expected to drive business development and improve operational efficiency.
- Market Reaction: Although specific details of the appointment have not been disclosed, the market generally holds a neutral stance on the management change, with no significant impact on stock prices.
- Company Vision: Westlake Chemical Partners remains committed to optimizing its strategic direction through executive changes to address industry challenges and seize market opportunities.
See More
Westlake Chemical Partners Q1 2026 Earnings Call Insights
- Stable Financial Performance: Westlake Chemical Partners reported a net income of $14 million for Q1 2026, translating to $0.40 per unit, which is $9 million higher than the same period in 2025, primarily driven by increased production and sales volumes, demonstrating the company's resilience amid market volatility.
- Cash Flow and Distribution: The partnership generated $18 million in distributable cash flow for the quarter, or $0.51 per unit, with a trailing 12-month coverage ratio improving from 0.8x to 1x, indicating enhanced cash generation and capital allocation, which boosts investor confidence.
- Management Transition: The company announced that Jon Baksht will join as CFO on June 15, with Steve Bender transitioning to Special Adviser, aiming to optimize financial management and support future strategic growth initiatives.
- Optimistic Market Outlook: The disruption in raw material supply due to the Middle East conflict has led to increased demand and prices for North American ethylene, with management anticipating continued opportunities for third-party sales, although most ethylene sales remain under fixed-margin agreements, ensuring business stability.
See More
Westlake Chemical Partners Reports Strong Q1 Earnings
- Significant Earnings Growth: Westlake Chemical Partners reported a Q1 GAAP EPS of $0.40, indicating a strong performance and enhanced profitability compared to the previous year, which reflects the company's resilience in the market.
- Substantial Revenue Increase: The company achieved revenues of $305.68 million in Q1, marking a 28.6% year-over-year growth, showcasing sustained demand in the chemical sector and further solidifying its market position.
- Executive Appointment: Westlake Chemical Partners appointed Jonathan Baksht as CFO, aiming to strengthen financial management and strategic planning to support the company's long-term growth objectives.
- Attractive Dividend Yield: Amid market volatility, Westlake Chemical Partners ranks among the top ten material stocks with the highest dividend yield, drawing investor interest and potentially enhancing shareholder returns and market appeal.
See More
Westlake Chemical Partners Declares Quarterly Dividend
- Quarterly Dividend Announcement: Westlake Chemical Partners declares a quarterly dividend of $0.4714 per share, consistent with previous distributions, demonstrating the company's ongoing commitment to stable cash flow and shareholder returns.
- Forward Yield: The forward yield of 8.32% positions the company attractively for investors seeking stable income amidst volatile markets, enhancing its appeal in the capital markets.
- Record Date for Shareholders: The dividend will be payable on June 1, with a record date of May 14 and an ex-dividend date also on May 14, providing investors with a clear timeline for their investment decisions.
- Financial Transparency: Westlake Chemical Partners offers a dividend scorecard, yield chart, and dividend growth information, further enhancing transparency and trust among investors regarding the company's financial health.
See More
Westlake Chemical Partners to Announce Q1 Earnings on May 5
- Earnings Announcement Schedule: Westlake Chemical Partners is set to release its Q1 2023 earnings report on May 5 before market open, with a consensus EPS estimate of $0.40, providing crucial insights into the company's recent financial performance for investors.
- Market Expectation Analysis: This earnings release will be a pivotal moment for investors to assess Westlake Chemical Partners' financial health, especially against the backdrop of increasing market volatility, as analyst expectations for profitability will directly impact stock price movements.
- High Dividend Stock Focus: Amid heightened market uncertainty, Westlake Chemical Partners is listed among the top ten material stocks with the highest dividend yield, which may attract income-seeking investors and further enhance its market appeal.
- Management Changes: Westlake Chemical Partners recently appointed Jonathan Baksht as CFO, a move that could bring new financial strategic direction to the company, influencing future financial decisions and investor confidence.
See More
Westlake Chemical Partners Appoints New CFO
- Executive Appointment: Westlake Chemical Partners has appointed Jonathan Baksht as CFO effective June 15, 2026, replacing retiring M. Steven Bender, and Baksht's extensive experience in oil and gas, packaging, and building products is expected to bring new financial strategies to the company.
- Background Overview: Baksht previously served as EVP and CFO at Fortune Brands Innovations and held CFO positions at Pactiv Evergreen and Valaris, and his diverse industry background is anticipated to enhance Westlake's financial management capabilities.
- Board Role: Baksht will also assume the role of director at Westlake Chemical Partners GP LLC on the same date, further strengthening his influence in corporate governance, which is expected to improve the company's financial transparency and strategic decision-making.
- Future Outlook: Westlake Chemical anticipates a recovery in distributable cash flow in 2026, and Baksht's addition may accelerate this process, especially with no planned major turnarounds, thereby boosting market confidence in the company's financial health.
See More
Westlake Chemical Partners Appoints New Executive
- Executive Appointment: Westlake Chemical Partners (WLKP) announced a new executive appointment late Monday, aimed at enhancing the management team's expertise and market competitiveness.
- Strategic Shift: This appointment reflects the company's focus on future growth, which is expected to drive business development and improve operational efficiency.
- Market Reaction: Although specific details of the appointment have not been disclosed, the market generally holds a neutral stance on the management change, with no significant impact on stock prices.
- Company Vision: Westlake Chemical Partners remains committed to optimizing its strategic direction through executive changes to address industry challenges and seize market opportunities.
See More
